Table 2 Metabolic in vitro stability of LEO 134310 in mouse, rat, dog, minipig and human whole blood and hepatocytes and in vivo PK parameters in rat and dog. Predicted hepatic clearance (CLH) from hepatocytes (well stirred model). Mean values ± S.D.

From: Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment

Parameter

Rat

Dog

Minipig

Human

In vitro (blood) half-life (min)

2.2 (2.1, 2.2) (n = 2)

3.3 ± 2.1 (n = 5)

3.8 (n = 1)

4.4 ± 2.2 (n = 4)

In vitro (hepatocytes) CLH (mL/min/kg)

57 (n = 1)

> 30 (n = 1)

> 35 (n = 1)

> 18 (n = 1)

In vivo clearance (mL/min/kg)

360 ± 85 (n = 3)

470 ± 97 (n = 3)

In vivo terminal half-life (min)

190 ± 171 (n = 3)

11 ± 1.2 (n = 3)